Interview with Todd Dollinger in Deal Street Asia

Trendlines to stay focused on medtech, agtech themes: CEO Todd Dollinger

By Shiwen Yep, DealStreetAsia

Israel-based Trendlines Group conducted its initial public offering (IPO) on the Singapore Exchange’s Catalist board, in a move that saw the firm raise US$27.5 million.

Since listing in Singapore, the firm plans to launch an incubator in Singapore, as well as an additional incubator in Germany, following a corporate partnership with a large German multinational corporation (MNC).

In an interview with DEALSTREETASIA, Todd Dollinger, joint chief executive and co-chairman of the Israeli Trendlines Group, shares his insights into agricultural technology, discussing its history and what led it to list in Singapore.

Trendlines Asia Road Show - July 2016 - Shanghai, China

Trendlines Chairman and CEO Todd Dollinger speaks to event attendees after the Trendlines Asia Road Show event in Singapore on 4 July 2016.

 What led to the inception of Trendlines and your long-term collaboration and partnership with Steve Rhodes? We met working at a medical device firm in Israel in 1991.

Steve was working as a CFO, I was in the marketing department and responsible for part of the product. It was a startup with 60 people; producing a medical device. We developed a relationship with one of the large enterprises in the anaesthesiology business, a German firm. This was at a time when Israel had no VC funds. We raised a few million in cash from the US through private placements.


What led you to list Trendlines on the Singapore Exchange (SGX), rather than a bourse closer to home like Tel Aviv or in a major Israeli trading partner like the US? Initially, Trendlines wanted to list in Toronto. What happened there that caused the deal to fail and what were the learnings from that which were implemented when Trendlines listed in Singapore? Why Singapore?

Tel Aviv is a small and shrinking market. We took two companies public in Tel Aviv, with one continuing to be traded and one that was sold. We will continue to take ventures public in Tel Aviv depending on the business model for our portfolio firms.

Read the full interview on DealStreetAsia.

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

Font Resize